Beruflich Dokumente
Kultur Dokumente
ก
%&' ()* +
,-../ 0
%)* ก &' (+
02?
:
E-Mail: chinekhob@gmail.com
1
1-1 !
R',R/,.[ R0ก ,<*<\ 1 (L-1) "#$%
ก
"(
)*%(*(")
ก --> ก(,
--> !"#$%
$( "2 40 "5&'6&
!ก(
ก7&"8
ก
!
-->
$
ก&'ก&'ก( ก&' !
460 "5 ก .). Hippocrates "$E%$ก&ก +
กก
#FF
ก
ก !$)*%!
ก ก
กG!,ก!(&'$ ' ก(
!&*((+%ก(
--> (
!
+&ก),ก-
ก " . *
' ! . (
$)-&' 16 Fracastoro %$
!& +
*#
$
# !I*ก(F 3 ก* กก) !#
6(I(ก!
2
1-1 ! 1-1 !
"#$%
ก "#$%
ก
"(
)*%(*(")
ก --> ()
ก (Epidemiology) --> ,Sc)7 ก *<\
.).1854 John Snow ก7F*(กก
ก#&'ก
,
&ก(
adกe 4กef&ก ,ก)( ก ก&
R0ED =&g4Rg 6S&7 ก
&
F"ก&'ก(
-(*
G"" 2
-( !*I*"F -e
-5d0ก D ,/=&Sh
4ก8 (*<\-<)*:)*8 6,ก)(
"
2ก""l_
G&' กก(W !&'
-(FG"8
G"" ก7GWกก
# กก( (*((
(F&ก(ก$
=&=ก&
Rd[
ก#ก
ก Vibrio Cholerae) – epi --> on, upon -->
.).1954 Salk Vaccine filed trail FGก! Vaccine "pก(#"!
# – demos --> people, human population --> "$$ ("$ก-%)
W7ก(ก&ก ! *G7 – logy --> the study of, knowledge --> ก),ก-, , )*%
40-< &,<(*<\ 6
*<\2(*2S<ก- ก /)(/ -/2(*<\
http://th.wikipedia.org/wiki/&' ()*
3
1-1 ! 1-1 !
"#$%
ก "#$%
ก
ก --> ()
ก --> ()
– Endemic (EDS&
8 5)\): Refers to a disease or infection that is particular
)0 R-*<\
,.\* 'R (=&ก ก&
R0ED=&g4Rg 67-7 6 5ก/0 E(67):<ก '- ,<',<0 ),D &
=SD -- =&
-)/)*<\,ก<\ก4' 'DD (Person) , (Time) =&5 *<\ (Place) 8 ,R- ,.\S&,-)g *<\*8 62(D8 /'6ก S4'S0=&
,.\* ' ,/R0ED=&g4Rg 4p 0 : fR )* ก &' (
&7'ก5d0ED =&g4
Rg *<\,ก)(Rd[ -<D -=/ก/ 0ก4 02 =&,Scg &,<06(
,.\* ':-7 /)R0ก ,ก)(ED=&g4Rg Sh
4
1-1 ! 1-1 !
"#$%
ก "#$%
ก
"#$%
ก --> ก
"#$%
ก -->
$ก
5
1-2
$
ก ก&' ! 1-2
$
ก ก&' !
กก($)*%!
ก กก($)*%!
ก
$
ก --> ()
$&'ก&' $ ก&' ! กก(z -->
"7
ก $)*%!
ก
,7a /
D))ก (Clinical medicine) "$ก&'ก&' "$กW$$(
6"g}&'(
ก
:))* (Pathology)
),ก-กก#W$$ ก ),ก-ก
}( !ก(ก-#
7<)* (Microbiology) * ** กก"pก(
!#
S )/)* (Parasitology)
' (ก
6"g&'(
ก
7<5)/) (Biostatistics)
*((+% 1 : many 1:1
S&7 กa /
(Demography) (ก
$$&"$ก
ก2{%&'W$(*G7 G"$ก&'F7"g G6"g&' (ก- !
.\ l ,7 ,7a /
74/ 40<)* ...
1-3 (
!
+&ก),ก-
ก 1-3 (
!
+&ก),ก-
ก
" . " .
!(กก&'W$Wก),ก-
ก --> &'
2
+&ก),ก-
ก --> & 3 "
ก ,ก)(ED (Disease occurrence) S&ก'(D (Host) /4กED )* ก &' (,7)0f (Descriptive epidemiology)
(Agent) =&)\0=(- (Environment)
)* ก &' (,7)0),D &
(Analysis epidemiology)
ก ก&
R0ED (Disease distribution) S&ก'( , (Time)
5 *<\ (Place) =&4กef&'DDR0S _ (Person) ก adกe 2SR 0 (Prospective Study)
)\0ก8 ( (Determinant) D.Sh
6
1-3 (
!
+&ก),ก-
ก 1-3 (
!
+&ก),ก-
ก
" . " .
+&ก),ก-
ก --> ()
+&ก),ก-
ก --> ()
)* ก &' (,7)0f (Descriptive epidemiology) )* ก &' (,7)0),D &
(Analysis epidemiology)
adกe ED&2 (what) ,ก)(ก4'6D (who) *<\2 (where) =&,ก)( ,ScR4[/
ก)* ก &' (,7)0f ,.\/'D8 5 -/ ,ก)(Rd[
,-.\2 (when) 2( 02 (How) E(,2S*<\ก adกe D -4-4:
R0Sh
4*<\
,.\67
4(8 (4'D -8 D4j --> PDCA D. 0=So0ก4=&D'D- ,Sc ,/R0ED/g4Rg ud\0
&/0-<ก 8
7-7 ก
ED&&/ 0 l --> (8 ,)ก =ก2RShj --> S&,-) --> S4'6- 'ก &' ( .ก )
4* 0)* ก &' (,Sc,D.\0-.
.*8 u[8 (8 ,)ก ='02(,Sc...
ก adกe S=''<[
8 ,Sc/0-<R-,ก<\ก4'ED 0D'5 5ก/0
=&(,k
1-3 (
!
+&ก),ก-
ก 1-3 (
!
+&ก),ก-
ก
" . " .
+&ก),ก-
ก --> ()
+&ก),ก-
ก --> ()
)* ก &' (,7)0),D &
(Analysis epidemiology) (/) )* ก &' (,7)0*(0 (Experimental epidemiology)
ก adกe 2SR 0 (Prospective Study) ,Scก ,S<',*<''4/)ก f
• ,Scก adกe E(67S=''ก *(0* 0D))ก .ก *(06
6,.\0,/ Sh
4,<\0/ก ,ScED • 4กก 8 D4jD. 4ก Max Min Con 2(=ก ...
ก adกe f
(, 6(, d\0 (Cross-sectional Study) ,Scก adกe
,.\:)' 5d0D -4-4:
R00D
S&ก'/ 0 l ก4'ED
7
1-3 (
!
+&ก),ก-
ก 1-3 (
!
+&ก),ก-
ก
" . " .
+&ก),ก-
ก --> () กG
ก --> 3 !(ก-2
)* ก &' (,7)0*(0 (Experimental epidemiology) (/) ก ,~o &40* 0)* ก &' ( (Epidemiological Surveillance)
– Maximized systematic variance - 5d0 ก *8 6D D -=SS ,Scก)
ก-6ก /)(/ -'-R-ก ,ก)(ED/(, ,.\* '
& 0ก-*(0-<D 0(4
&7Sก )
42(5ก/0
D -,S<\=S0 --> 0.506
– Minimized error variance - 5d0 ก -(D -=SSg 6
ก-*(0.D D -=SS.\l*<\2- - 5D'D-2(6-<D /\8 ( ก '* 0)* ก &' ( (Epidemiological Investigation)
):<ก ( error variance D. 1) -6ก-/4 0*<\67adกe 6ก- ,Scก D R,*k